Goff Brian
SEC insider (Form 3/4/5 filer). CIK 0001546216. Chief Executive Officer at AGIOS PHARMACEUTICALS, INC. (AGIO) and 1 other issuer. 32 reported Form 4/5 transactions since Sep 2024; latest on Jun 18, 2026. Located in CAMBRIDGE, MA.
Companies Goff Brian has filed insider reports for
- AGIOS PHARMACEUTICALS, INC. (AGIO): Director, Officer, Chief Executive Officer
- Intellia Therapeutics, Inc. (NTLA): Director
Goff Brian
CIK: 0001546216
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (32 total)
- Jun 18, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
AwardDirectRestricted stock units
39K shares- - Jun 18, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
ExerciseDirectPerformance share units
39K shares- - Jun 9, 2026NTLA
Intellia Therapeutics, Inc.
AwardDirect9.2K shares- - Apr 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
ExerciseDirect13.5K shares- - Apr 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
ExerciseDirect25.5K shares- - Apr 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
SaleDirect6.6K shares at avg. $34.71$229K - Apr 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
SaleDirect12.5K shares at avg. $34.71$433K - Mar 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
SaleDirect3.9K shares at avg. $28.96$112K - Mar 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
ExerciseDirect8.5K shares- - Mar 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
ExerciseDirect13K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 18, 2026 |  AGIO AGIOS PHARMACEUTICALS, INC. | Award Restricted stock units | 39,000 | - | - | Direct |
| Jun 18, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise Performance share units | 39,000 | - | - | Direct |
| Jun 9, 2026 |  NTLA Intellia Therapeutics, Inc. | Award | 9,200 | - | $0 | Direct |
| Apr 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise | 13,500 | - | $0 | Direct |
| Apr 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise | 25,528 | - | $0 | Direct |
| Apr 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale | 6,596 | $34.71 | $228,947 | Direct |
| Apr 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale | 12,472 | $34.71 | $432,903 | Direct |
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale | 3,870 | $28.96 | $112,075 | Direct |
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise | 8,500 | - | $0 | Direct |
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise | 13,000 | - | $0 | Direct |
1-10 of 32 transactions